Explore the detailed record of transactions filed by Liu Jean I. Director active across 2 companies, notably Seagen Inc.. In total, 29 filings have been published. Split: 0 buy · 9 sells. Total volume traded: €1.3m. Activity tracked since 11 May 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Liu Jean I
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
LIU JEAN I is a declarant with 29 filings in total. In the 29 recent sampled filings, the activity runs from 2021-05-13 to 2026-07-01, with 0 EUR of buys and 11543124 EUR of sells, and the modal transaction nature is Attribution. He is Chief Legal Officer at Seagen Inc. and Director at Connect Biopharma Holdings Ltd.